Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.88
+0.45 (8.29%)
At close: Jun 26, 2026, 4:00 PM EDT
5.71
-0.17 (-2.89%)
After-hours: Jun 26, 2026, 7:38 PM EDT
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$307,037
Profits / Employee
-$148,111
Market Cap
555.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 942 |
| GRAIL | 910 |
| CareDx | 765 |
| Biodesix | 334 |
MYGN News
- 5 days ago - Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication - GlobeNewsWire
- 24 days ago - Myriad Genetics Transcript: AGM 2026 - Transcripts
- 26 days ago - Myriad Genetics appoints Raj Jampa as chief technology officer - TheFly
- 26 days ago - Myriad Genetics Names Raj Jampa as New Chief Technology Officer - GlobeNewsWire
- 4 weeks ago - Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting - GlobeNewsWire
- 4 weeks ago - Myriad Genetics launches Prolaris + AI - TheFly
- 4 weeks ago - Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI) - GlobeNewsWire
- 6 weeks ago - Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life - GlobeNewsWire